Fixed-dose isosorbide dinitrate-hydralazine: race-based cardiovascular medicine benefit or mirage? |
| |
Authors: | Keith C Ferdinand |
| |
Affiliation: | Cardiology Division, Emory University, USA. |
| |
Abstract: | Race is not a scientific category, but African Americans have increased prevalence and severity of heart failure. The African American Heart Failure trial showed the benefit of a combination of isosorbide dinitrate (a nitric oxide donor) and hydralazine (an antioxidant). Future research may unmask the reason for cardiovascular differences in therapy. |
| |
Keywords: | |
|
|